Mercatus Capital

New Business

Singapore’s Nanyang Biologics to list on Nasdaq amid Trump’s tariffs on pharma imports

“The US administration wants intellectual property owners to manufacture in the US, including drugs,” founder Roland Ong said on Monday.…

Read More »
Back to top button